Medical expenditures attributable to cerebral palsy and intellectual disability among Medicaid-enrolled children

► Medical expenditures were examined for children with cerebral palsy. ► Data from 2005 MarketScan® Medicaid Multi-State database were examined. ► Children with cerebral palsy incurred high medical expenditures. ► Medical expenditures tripled due to co-occurring intellectual disability. ► Our study...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Research in developmental disabilities 2012-05, Vol.33 (3), p.832-840
Hauptverfasser: Kancherla, Vijaya, Amendah, Djesika D., Grosse, Scott D., Yeargin-Allsopp, Marshalyn, Van Naarden Braun, Kim
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:► Medical expenditures were examined for children with cerebral palsy. ► Data from 2005 MarketScan® Medicaid Multi-State database were examined. ► Children with cerebral palsy incurred high medical expenditures. ► Medical expenditures tripled due to co-occurring intellectual disability. ► Our study results have utility to publicly insured children with cerebral palsy. This study estimated medical expenditures attributable to cerebral palsy (CP) among children enrolled in Medicaid, stratified by the presence of co-occurring intellectual disability (ID), relative to children without CP or ID. The MarketScan® Medicaid Multi-State database was used to identify children with CP for 2003–2005 by using the International Classification of Diseases, Ninth Revision; Clinical Modification (ICD-9-CM) code 343.xx. Children with ID were identified for 2005 by using ICD-9-CM code 317.xx–319.xx. Children without CP or ID during the same period served as control subjects. Medical expenditures were estimated for case and control children for 2005. The difference between the average expenditures for children with and without CP was used as a proxy for attributable expenditures for the condition. The attributable expenditures of co-occurring ID were calculated similarly as the difference in average expenditures among children with CP with and without ID. A total of 9927 children with CP were identified. Among them, 2022 (20.3%) children had co-occurring ID recorded in medical claims. Children with CP but without ID incurred medical expenditures that were $15,047 higher than those of control children without CP or ID. By contrast, children with CP and co-occurring ID incurred costs that were $41,664 higher, compared with control children, and $26,617 more than children with CP but without ID. Administrative data from a large, multistate database demonstrated high medical expenditures for publicly insured children with CP. Expenditures approximately tripled for children with CP and co-occurring ID.
ISSN:0891-4222
1873-3379
DOI:10.1016/j.ridd.2011.12.001